Austria
FetoLife Science is a pioneering digital women's health startup, founded in 2019 and headquartered in Austria. The company's slogan, "FetoLife is a digital women's health company with a focus on pregnancy health risk," encapsulates its core focus. FetoLife has developed a first-of-its-kind pregnancy app aimed at delivering daily personalized health insights and intelligent self-management tools to pregnant women in the U.S.
One of FetoLife's key innovations is its patient-centric technology, which includes a smart health assistant designed for digital, advanced pregnancy risk assessment and symptom management. Through the use of advanced analytics and the latest medical knowledge, the company continuously tracks pregnant women's health and provides personalized health insights and information based on individual health data.
With a dedicated team comprising physicians, scientific researchers, and engineers, FetoLife is at the forefront of developing the next generation of digital health solutions for pregnant women. The company's mission is to empower pregnant women by providing them with easy-to-use digital tools that enable them to take control of their own and their babies' health, all from the comfort of their smartphones.
The most recent investment in FetoLife was a €1.00M Seed Round investment at 01 January 2020, led by Handler Invest. With a focus on enhancing the diagnosis, clinical monitoring, and management of pregnancy health outside of traditional care settings, FetoLife has demonstrated the potential to make a significant impact in the health care industry.
